Inhibition of atopic dermatitis by topical application of silymarin in NC/Nga mice
- PMID: 18593606
- DOI: 10.1016/j.intimp.2008.06.004
Inhibition of atopic dermatitis by topical application of silymarin in NC/Nga mice
Abstract
Silymarin has been known to inhibit chemical-induced irritant contact dermatitis. In the present study, we report that topical application of silymarin suppresses dust mite extract (DPE)-induced atopic dermatitis (AD) in NC/Nga mice. Repeated topical application of ears with DPE caused AD-like skin lesions in NC/Nga mice. However, silymarin reduced AD-like skin lesions in these mice, resulting in decreased ear swelling and leukocyte infiltration into the ear. Moreover, our results showed that mast cell infiltration into the ear was suppressed by silymarin treatment in DPE-treated NC/Nga mice. Silymarin also reduced plasma level of IL-4 and IgE in these mice. Further study demonstrated that the mRNA expression of IL-4 was increased and that of IFN-gamma was decreased by DPE treatment in the ears of NC/Nga mice. However, DPE-induced changes in IL-4 and IFN-gamma mRNA expression were reversed by silymarin. DPE-induced increase in TNF-alpha mRNA expression was also suppressed by silymarin treatment. The results presented in this report suggest that silymarin might be beneficial for the treatment of AD.
Similar articles
-
Induction of atopic eczema/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga mice.Int Immunopharmacol. 2006 Oct;6(10):1616-22. doi: 10.1016/j.intimp.2006.06.011. Epub 2006 Jul 18. Int Immunopharmacol. 2006. PMID: 16919834
-
Topical application of a novel ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice.Int Immunopharmacol. 2007 Dec 15;7(13):1589-97. doi: 10.1016/j.intimp.2007.08.009. Epub 2007 Sep 4. Int Immunopharmacol. 2007. PMID: 17996668
-
Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, in NC/Nga mice.Exp Dermatol. 2008 Nov;17(11):958-64. doi: 10.1111/j.1600-0625.2008.00737.x. Epub 2008 Aug 20. Exp Dermatol. 2008. PMID: 18721197
-
Animal models for atopic dermatitis: are they relevant to human disease?J Dermatol Sci. 2004 Oct;36(1):1-9. doi: 10.1016/j.jdermsci.2004.02.013. J Dermatol Sci. 2004. PMID: 15488700 Review.
-
[Silymarin-containing phytopharmaceuticals--biopharmacy as an essential therapeutic quality criterion].Z Arztl Fortbild Qualitatssich. 1999 Jun;93(4):VI-XI. Z Arztl Fortbild Qualitatssich. 1999. PMID: 10432565 Review. German. No abstract available.
Cited by
-
Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis.Drug Deliv Transl Res. 2012 Apr;2(2):129-41. doi: 10.1007/s13346-012-0060-8. Drug Deliv Transl Res. 2012. PMID: 25786721
-
Echinochrome A Treatment Alleviates Atopic Dermatitis-like Skin Lesions in NC/Nga Mice via IL-4 and IL-13 Suppression.Mar Drugs. 2021 Nov 1;19(11):622. doi: 10.3390/md19110622. Mar Drugs. 2021. PMID: 34822493 Free PMC article.
-
High-intensity swimming exercise increases dust mite extract and 1-chloro-2,4-dinitrobenzene-derived atopic dermatitis in BALB/c mice.Inflammation. 2014 Aug;37(4):1179-85. doi: 10.1007/s10753-014-9843-z. Inflammation. 2014. PMID: 24526290
-
Anti-inflammatory and Anti-oxidative Effects of Korean Red Ginseng Extract in Human Keratinocytes.Immune Netw. 2011 Feb;11(1):42-9. doi: 10.4110/in.2011.11.1.42. Epub 2011 Feb 28. Immune Netw. 2011. PMID: 21494373 Free PMC article.
-
Impact on inflammation and recovery of skin barrier by nordihydroguaiaretic Acid as a protease-activated receptor 2 antagonist.Biomol Ther (Seoul). 2012 Sep;20(5):463-9. doi: 10.4062/biomolther.2012.20.5.463. Biomol Ther (Seoul). 2012. PMID: 24009835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical